Ray Dalio Axsome Therapeutics, Inc. Transaction History
Bridgewater Associates, LP
- $23.3 Billion
- Q2 2025
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 107,292 shares of AXSM stock, worth $12.7 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
107,292
Previous 42,825
150.54%
Holding current value
$12.7 Million
Previous $4.99 Million
124.27%
% of portfolio
0.05%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding AXSM
# of Institutions
403Shares Held
37.4MCall Options Held
507KPut Options Held
540K-
Vanguard Group Inc Valley Forge, PA3.95MShares$468 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$392 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$201 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$180 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$135 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.09B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...